Rani Therapeutics to Participate in May Investor Conferences
Rani Therapeutics, a clinical-stage biotherapeutics company focused on oral delivery of biologics and drugs, announced participation in two investor conferences in May 2024. The H.C. Wainwright 2nd Annual BioConnect Investor Conference will be held on May 20th at Nasdaq Headquarters, New York City, featuring a fireside chat and 1x1 investor meetings with CEO Talat Imran. The UBS Spring Biotech Conference will take place on May 21st at UBS, New York City, consisting of 1x1 investor meetings. Live webcast for the H.C. Wainright Conference will be available on Rani's website.
- Rani's participation in high-profile investor conferences could increase visibility and attract potential investors.
- CEO Talat Imran's fireside chat at the H.C. Wainwright Conference may provide valuable insights about the company's strategy.
- 1x1 investor meetings at both conferences offer personalized engagement opportunities with key stakeholders.
- No immediate financial or clinical data updates were provided, which may not satisfy investors looking for tangible progress.
- Webcast replay availability post-event may limit real-time engagement and immediate feedback.
SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in two upcoming investor conferences in May 2024. These conferences include:
H.C. Wainwright 2nd Annual BioConnect Investor Conference
Location: The Nasdaq Headquarters, New York City
Date: Monday, May 20th at 2:30pm E.T
Format: Fireside Chat and 1x1 Investor Meetings
Presenter: Chief Executive Officer, Talat Imran
UBS Spring Biotech Conference
Location: UBS, New York City
Date: Tuesday, May 21st, 2024
Format: 1x1 Investor Meetings
Interested parties can register for and access the live webcast for the H.C. Wainright Conference by visiting the “Events” section of the Rani Therapeutics website. The webcast replay will be available after the conclusion of the presentation.
About Rani Therapeutics
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill capsule technology. For more information, visit ranitherapeutics.com.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
FAQ
What is Rani Therapeutics' focus?
When will Rani Therapeutics participate in the H.C. Wainwright BioConnect Investor Conference?
Where is the H.C. Wainwright 2nd Annual BioConnect Investor Conference located?
What format will Rani Therapeutics participate in during the H.C. Wainwright Conference?
Who will present at the H.C. Wainwright Conference on behalf of Rani Therapeutics?
When is the UBS Spring Biotech Conference taking place?
What is the format of Rani Therapeutics' participation in the UBS Spring Biotech Conference?
How can interested parties access the H.C. Wainwright Conference webcast?
Will the webcast replay of the H.C. Wainwright Conference be available?
